MRPL49 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.856000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.320000E-01
Normal-vs-Stage2
9.265600E-01
Normal-vs-Stage3
1.210410E-01
Normal-vs-Stage4
9.221200E-01
Stage1-vs-Stage2
9.610200E-01
Stage1-vs-Stage3
7.105600E-02
Stage1-vs-Stage4
9.463800E-01
Stage2-vs-Stage3
5.590000E-02
Stage2-vs-Stage4
9.875800E-01
Stage3-vs-Stage4
1.463950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.776600E-01
Normal-vs-AfricanAmerican
7.028800E-01
Normal-vs-Asian
7.004200E-01
Caucasian-vs-AfricanAmerican
4.569200E-01
Caucasian-vs-Asian
6.380800E-01
AfricanAmerican-vs-Asian
3.722800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.892200E-01
Normal-vs-Female
9.834000E-01
Male-vs-Female
3.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.566400E-01
Normal-vs-Age(41-60Yrs)
6.466200E-01
Normal-vs-Age(61-80Yrs)
6.842400E-01
Normal-vs-Age(81-100Yrs)
5.899200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.798200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.548400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.548600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.998600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.443800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.214600E-01
Normal-vs-Daily Drinker
9.705800E-01
Normal-vs-Weekly Drinker
3.209800E-01
Normal-vs-Occasional Drinker
6.077000E-01
Normal-vs-Social Drinker
9.685000E-01
Non Drinker-vs-Daily Drinker
4.504800E-01
Non Drinker-vs-Weekly Drinker
7.662600E-01
Non Drinker-vs-Occasional Drinker
9.216100E-02
Non Drinker-vs-Social Drinker
4.517400E-01
Daily Drinker-vs-Weekly Drinker
3.846800E-01
Daily Drinker-vs-Occasional Drinker
3.743000E-01
Daily Drinker-vs-Social Drinker
9.719000E-01
Weekly Drinker-vs-Occasional Drinker
1.029040E-01
Weekly Drinker-vs-Social Drinker
3.688400E-01
Occasional Drinker-vs-Social Drinker
3.965600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.638800E-01
Normal-vs-Grade 2
6.908800E-01
Normal-vs-Grade 3
6.239000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.012390E-01
Grade 1-vs-Grade 3
1.159700E-02
Grade 1-vs-Grade 4
4.638800E-01
Grade 2-vs-Grade 3
1.091000E-01
Grade 2-vs-Grade 4
6.908800E-01
Grade 3-vs-Grade 4
6.239000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.708600E-01
Normal-vs-NonDiabetic
9.941400E-01
Diabetic-vs-NonDiabetic
8.122000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.875600E-01
Normal-vs-NoPancreatitis
7.939400E-01
Pancreatitis-vs-NoPancreatitis
8.184500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.842000E-01
Normal-vs-N1
8.990600E-01
N0-vs-N1
9.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.368400E-01
Normal-vs-TP53-NonMutant
8.976400E-01
TP53-Mutant-vs-TP53-NonMutant
9.53679999999846E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
